http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103102359-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd7e8012670262f387cdff8f903cfece
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93d9140164dbb51b546a17e62c0f27b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_707f6b52c2a0719abd57061601fe50aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78e47cba3221da19ff0e26c60bde3f82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f1131693da26d15951391195a2b17fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_924b3dab9cc9ce0918f62c9fc58d8428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d85b1fac5f708d666961b1618ff7220a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a9a39ca3c815c8623bb0f5d94f8c2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90fafdd45ee17da571934f740c33abbf
publicationDate 2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103102359-A
titleOfInvention Pyrimidine compounds and their applications
abstract The present invention relates to the field of biomedicine, in particular to pyrimidine compounds and applications thereof, that is, compounds of general formula (I) and pharmaceutically acceptable equivalents or salts thereof. The compounds of the present invention can be used as Janus kinase inhibitors for various medical purposes .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104177363-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104177363-A
priorityDate 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009064835-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008031594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101516860-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008109943-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467869625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72202092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72202094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428485364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428485362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467017396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467061103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465213095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467058565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163600771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467521918

Total number of triples: 48.